Can training doctors help pregnant women with opioid addiction get better care?

NCT ID NCT04527926

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a training program for prenatal healthcare providers to help them use medication-assisted treatment (MAT) for opioid use disorder during pregnancy. Researchers looked at data from over 1,000 patients to see if the program increased use of MAT and improved health outcomes for mothers and babies. The program included education, teleconsultation, and support from health system administrators.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this program could show how to increase evidence-based treatment for pregnant women with opioid use disorder, improving health for mothers and babies.

What could go wrong

This is a completed study testing a provider training program, not a direct treatment. Results may not apply to all settings or guarantee better patient outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Magee Womens Hospital of UPMC

    Pittsburgh, Pennsylvania, 15213, United States